KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Bionano Genomics (BNGO) Long-Term Debt Repayments (2018 - 2025)

Bionano Genomics (BNGO) has disclosed Long-Term Debt Repayments for 6 consecutive years, with $1.9 million as the latest value for Q3 2025.

Quarterly Long-Term Debt Repayments rose 20.5% to $1.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Dec 2025, down 2.5% year-over-year, with the annual reading at $4.9 million for FY2025, 2.5% down from the prior year.
Long-Term Debt Repayments hit $1.9 million in Q3 2025 for Bionano Genomics, up from $1.5 million in the prior quarter.
In the past five years, Long-Term Debt Repayments ranged from a high of $17.0 million in Q2 2021 to a low of -$2.0 million in Q4 2021.
Historically, Long-Term Debt Repayments has averaged $3.1 million across 3 years, with a median of $1.5 million in 2024.
Biggest five-year swings in Long-Term Debt Repayments: soared 486.55% in 2021 and later increased 3.88% in 2025.
Year by year, Long-Term Debt Repayments stood at -$2.0 million in 2021, then soared by 199.5% to $2.0 million in 2024, then dropped by 6.25% to $1.9 million in 2025.
Business Quant data shows Long-Term Debt Repayments for BNGO at $1.9 million in Q3 2025, $1.5 million in Q2 2025, and $1.5 million in Q1 2025.